Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children (Clinical Trial I)

NCT02380235 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Growth Hormone Deficiency

Interventions

BIOLOGICAL: PEG-somatropin
BIOLOGICAL: PEG-somatropin

Sponsor

Changchun GeneScience Pharmaceutical Co., Ltd.